Dr Stephanie Hemm, MD | |
8000b Loch Raven Blvd, Towson, MD 21286-8337 | |
(410) 830-2196 | |
(410) 830-2198 |
Full Name | Dr Stephanie Hemm |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 8000b Loch Raven Blvd, Towson, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154415065 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | D69692 (Maryland) | Primary |
Entity Name | Sinai Hospital Of Baltimore, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619992237 PECOS PAC ID: 0941112346 Enrollment ID: O20100721000741 |
News Archive
Levels of CoQ and the presence of insulin resistance were analyzed in a range of experimental laboratory settings, mouse models and samples from humans, as part of an ambitious research collaboration conducted with the University of Sydney, Victor Chang Cardiac Research Institute, Duke University School of Medicine, Garvan Institute of Medical Research, Genentech Inc. and the University of New South Wales.
Ongoing efforts by the Centers for Disease Control and Prevention to reduce the population impact of traumatic brain injury (TBI) are documented in the May/June issue of The Journal of Head Trauma Rehabilitation, official journal of the Brain Injury Association of America.
National Health Investors, Inc. announced today it will increase its first quarter dividend to $.77 per common share to shareholders of record on March 31, 2014 and payable on May 9, 2014. This represents an annualized dividend of $3.08 per common share, which is a 6.2% increase over the dividends declared for 2013.
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that the U.S. Food & Drug Administration has accepted the Company's investigational new drug application to begin clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate also known as Ad-RTS-IL-12 + AL, in oncology.
A study from the Tufts University School of Medicine published in the Journal of Clinical Pharmacology finds that pomegranate juice does not interact with oral or intravenous medication, contrary to previous information.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Stephanie Hemm, MD 8000b Loch Raven Blvd, Towson, MD 21286-8337 Ph: (410) 830-2196 | Dr Stephanie Hemm, MD 8000b Loch Raven Blvd, Towson, MD 21286-8337 Ph: (410) 830-2196 |
News Archive
Levels of CoQ and the presence of insulin resistance were analyzed in a range of experimental laboratory settings, mouse models and samples from humans, as part of an ambitious research collaboration conducted with the University of Sydney, Victor Chang Cardiac Research Institute, Duke University School of Medicine, Garvan Institute of Medical Research, Genentech Inc. and the University of New South Wales.
Ongoing efforts by the Centers for Disease Control and Prevention to reduce the population impact of traumatic brain injury (TBI) are documented in the May/June issue of The Journal of Head Trauma Rehabilitation, official journal of the Brain Injury Association of America.
National Health Investors, Inc. announced today it will increase its first quarter dividend to $.77 per common share to shareholders of record on March 31, 2014 and payable on May 9, 2014. This represents an annualized dividend of $3.08 per common share, which is a 6.2% increase over the dividends declared for 2013.
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that the U.S. Food & Drug Administration has accepted the Company's investigational new drug application to begin clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate also known as Ad-RTS-IL-12 + AL, in oncology.
A study from the Tufts University School of Medicine published in the Journal of Clinical Pharmacology finds that pomegranate juice does not interact with oral or intravenous medication, contrary to previous information.
› Verified 5 days ago
Dr. Richard Michael Silberg, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 515 Fairmount Ave, Suite 200, Towson, MD 21286 Phone: 410-494-2799 Fax: 410-494-1211 | |
Dr. Nicolette D Morris, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 7300 York Rd, Towson, MD 21204 Phone: 410-825-6420 Fax: 410-825-5819 | |
Alison Faye Decker, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8600 Lasalle Rd, Suite 105, Towson, MD 21286 Phone: 410-823-5232 | |
Melissa Emerson Lancer, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7601 Osler Dr, Towson, MD 21204 Phone: 410-337-1000 | |
Jeffries L.g. Bucci, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7600 Osler Drive, Suite 310, Towson, MD 21204 Phone: 410-296-2300 Fax: 410-296-3444 | |
Dr. Paul Zoltan Bodnar, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 849 Fairmont Avenue, Suite 100a, Towson, MD 21286 Phone: 410-494-1369 Fax: 410-494-2737 | |
Dr. Kristen Miller, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 7601 Osler Dr, Towson, MD 21204 Phone: 410-337-1120 |